Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 4.345
-0.150 (-3.34%)
At close: Jan 16, 2026
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €176.41 million as of January 20, 2026. Its market cap has decreased by -47.16% in one year.
Market Cap
176.41M
Enterprise Value
175.09M
Revenue
5.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.35
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 176.41M, a decrease of -57.77%. That is a compound annual growth rate of -14.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 177.05M | 0.73% |
| Dec 31, 2025 | 175.76M | -43.15% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 50.46B |
| argenx SE | 42.45B |
| Financière de Tubize | 10.48B |
| Fagron NV | 1.68B |
| Ion Beam Applications | 410.90M |
| Hyloris Pharmaceuticals | 221.20M |
| Onward Medical | 202.43M |
| Sequana Medical NV | 32.32M |